Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2018-01, Vol.218 (1), p.142-143
Main Authors: van Baaren, G.J., Bruijn, M.M.C., Mol, B.W.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c400t-2a0b95660582102bca42f007cf95d9bda628265856c2db20e5b3c530b2b647d3
cites cdi_FETCH-LOGICAL-c400t-2a0b95660582102bca42f007cf95d9bda628265856c2db20e5b3c530b2b647d3
container_end_page 143
container_issue 1
container_start_page 142
container_title American journal of obstetrics and gynecology
container_volume 218
creator van Baaren, G.J.
Bruijn, M.M.C.
Mol, B.W.
description
doi_str_mv 10.1016/j.ajog.2017.10.037
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1989536057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937817312309</els_id><sourcerecordid>1989536057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-2a0b95660582102bca42f007cf95d9bda628265856c2db20e5b3c530b2b647d3</originalsourceid><addsrcrecordid>eNp9kMtuHCEQRVEUKx4_fiCLiGU2Pa6mB7qxvIksJ7ZkyVLkPeJRPWHUAw4w8ePrQ3ucLL1CVZy6BYeQzy0sW2jF2WapN3G9ZND2tbGErv9AFi3IvhGDGD6SBQCwRnb9cEiOct7MJZPsEzlksgMO0C_I008dXNz6F3TUTj54qydaktdTpjohDbFQPT3q50zLL6QGc6G1oiVSnTPmTJ3X6xBz8ZaWepvPX0GrM9I40hFLDRy9STGgLT68Qj6sT8jBWJfg6dt5TO6_X91fXje3dz9uLr_dNnYFUBqmwUguBPCBtcCM1Ss21pfbUXInjdOCDUzwgQvLnGGA3HSWd2CYEavedcfk6z72IcXfu7pabX22OE06YNxl1cpB8q7G9xVle9SmmHPCUT0kv9XpWbWgZuFqo2bhahY-96rwOvTlLX9ntuj-j_wzXIGLPYD1k388JpWtx2DR-VSFKBf9e_l_Adi1kqs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989536057</pqid></control><display><type>article</type><title>Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing</title><source>ScienceDirect Journals</source><creator>van Baaren, G.J. ; Bruijn, M.M.C. ; Mol, B.W.</creator><creatorcontrib>van Baaren, G.J. ; Bruijn, M.M.C. ; Mol, B.W.</creatorcontrib><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2017.10.037</identifier><identifier>PMID: 29305007</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>American journal of obstetrics and gynecology, 2018-01, Vol.218 (1), p.142-143</ispartof><rights>2017 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-2a0b95660582102bca42f007cf95d9bda628265856c2db20e5b3c530b2b647d3</citedby><cites>FETCH-LOGICAL-c400t-2a0b95660582102bca42f007cf95d9bda628265856c2db20e5b3c530b2b647d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29305007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Baaren, G.J.</creatorcontrib><creatorcontrib>Bruijn, M.M.C.</creatorcontrib><creatorcontrib>Mol, B.W.</creatorcontrib><title>Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMtuHCEQRVEUKx4_fiCLiGU2Pa6mB7qxvIksJ7ZkyVLkPeJRPWHUAw4w8ePrQ3ucLL1CVZy6BYeQzy0sW2jF2WapN3G9ZND2tbGErv9AFi3IvhGDGD6SBQCwRnb9cEiOct7MJZPsEzlksgMO0C_I008dXNz6F3TUTj54qydaktdTpjohDbFQPT3q50zLL6QGc6G1oiVSnTPmTJ3X6xBz8ZaWepvPX0GrM9I40hFLDRy9STGgLT68Qj6sT8jBWJfg6dt5TO6_X91fXje3dz9uLr_dNnYFUBqmwUguBPCBtcCM1Ss21pfbUXInjdOCDUzwgQvLnGGA3HSWd2CYEavedcfk6z72IcXfu7pabX22OE06YNxl1cpB8q7G9xVle9SmmHPCUT0kv9XpWbWgZuFqo2bhahY-96rwOvTlLX9ntuj-j_wzXIGLPYD1k388JpWtx2DR-VSFKBf9e_l_Adi1kqs</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>van Baaren, G.J.</creator><creator>Bruijn, M.M.C.</creator><creator>Mol, B.W.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180101</creationdate><title>Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing</title><author>van Baaren, G.J. ; Bruijn, M.M.C. ; Mol, B.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-2a0b95660582102bca42f007cf95d9bda628265856c2db20e5b3c530b2b647d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Baaren, G.J.</creatorcontrib><creatorcontrib>Bruijn, M.M.C.</creatorcontrib><creatorcontrib>Mol, B.W.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Baaren, G.J.</au><au>Bruijn, M.M.C.</au><au>Mol, B.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>218</volume><issue>1</issue><spage>142</spage><epage>143</epage><pages>142-143</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29305007</pmid><doi>10.1016/j.ajog.2017.10.037</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2018-01, Vol.218 (1), p.142-143
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_1989536057
source ScienceDirect Journals
title Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A20%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Randomized%20clinical%20trials%20are%20not%20always%20the%20best%20way%20to%20assess%20diagnostic%20tests:%20the%20case%20of%20fetal%20fibronectin%20testing&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=van%20Baaren,%20G.J.&rft.date=2018-01-01&rft.volume=218&rft.issue=1&rft.spage=142&rft.epage=143&rft.pages=142-143&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2017.10.037&rft_dat=%3Cproquest_cross%3E1989536057%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c400t-2a0b95660582102bca42f007cf95d9bda628265856c2db20e5b3c530b2b647d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1989536057&rft_id=info:pmid/29305007&rfr_iscdi=true